HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hughes, J. R. Search for Related Content PubMed PubMed Citation Articles by Hughes, J. R.

CA: A Cancer Journal for Clinicians, Vol 50, Issue 3 143-151, Copyright © 2000 by American Cancer Society

ARTICLES

New treatments for smoking cessation

J. R. Hughes
Department of Psychiatry at the University of Vermont in Burlington, USA.

Helping cigarette smokers to permanently stop smoking is one of the most effective ways to prevent cancer. A physician's instruction to a patient to stop smoking and to offer assistance in this endeavor is an important motivator. Current guidelines state that clinicians should encourage all smokers who want to quit to use medications and should offer psychosocial therapies, as well. It has been shown that even brief clinician advice about smoking cessation increases quit rates. Five medications--bupropion, nicotine gum, nicotine inhaler, nicotine nasal spray, and nicotine patch--and one proven psychosocial therapy (behavior therapy) appear equally effective and safe; i.e., they all double quit rates and are associated with a less than 5% dropout rate due to adverse events. In 1998, approximately one third of those who attempted to quit smoking used a medication. Attending group behavior therapy to supplement medications increases quit rates but is not essential for medications to work. As there are no proven treatment-matching protocols, patients should choose the treatment(s) they believe will be most effective for them. In the future, people who continue to smoke will be individuals with severe nicotine dependence or psychiatric symptoms; thus, clinicians will increasingly be called on to provide pharmacotherapy for smoking cessation.

This article has been cited by other articles:

				C. J Bentz An intensive smoking cessation intervention reduced hospital admissions and mortality in high risk smokers with CVD Evid. Based Med., August 1, 2007; 12(4): 113 - 113. [Full Text] [PDF]

				D. L. Katz, J. Boukhalil, S. C. Lucan, D. Shah, W. Chan, and M.-C. Yeh Impediment Profiling for Smoking Cessation: Preliminary Experience Behav Modif, September 1, 2003; 27(4): 524 - 537. [Abstract] [PDF]

				M. Thun and T. J Glynn Improving the treatment of tobacco dependence BMJ, August 5, 2000; 321(7257): 311 - 312. [Full Text]